Healthcare Industry Updates and Innovation Conference

The Healthcare Landscape in South Africa  

The findings of the Competition Commission health-market inquiry and the consequent drive to uniform tariffs, as well as the imminent National Health Insurance (NHI) rollout, continued consolidation of medical aids and finally the inextricable rise in medial inflation, culminate in a perfect storm for the sector.  Against this backdrop of healthcare reform, medical technology companies are focused more than ever on products that deliver cheaper, faster, more efficient patient care. How do re-imbursement models need to change to facilitate disruptive innovation?

Topics:

  • Assessing the impact of NHI and the Health Market Inquiry on South Africa’s Healthcare Industry;

  • The New Healthcare Landscape: After NHI and the HMI: what will the future look like?;

  • Healthcare innovation in South Africa: hospitals, medical schemes, primary care markets;

  • Private, public partnerships: private care involvement in the NHI;

  • Unpacking the pharma-care landscape: technology and biotechnology infrastructure, the pharmaceutical value chain, access to world-class generics and vaccinations;

  • Innovation in health financing and health delivery;

  • Opportunities through blockchain: healthcare on the blockchain means a whole lot more than streamlined hospital visits;

  • Venture capital and innovation: what is the state of the healthcare start-up arena? What funding is available? What role does VC and PE play?;

  • Costs and operating models; and

  • Innovation in medical devices and other technology: against the backdrop of healthcare reform, medical technology companies are focused more than ever on products that deliver cheaper, faster, more efficient patient care. How do re-imbursement models need to change to facilitate disruptive innovation?

Speakers:

  • Dr Anban Pillay – DDG, National Health Insurance, National Department of Health;
  • Dr Katlego Mothudi, managing director, Board of Healthcare Funders of Southern Africa;
  • Dr Anchen Laubster, medical director, Netcare Limited;
  • Dr Ntuthuko Bhengu, commissioner of the National Planning Commission of South Africa, co-founder of Afrika Biopharma Investments (Pty) Ltd;
  • Adam Pyles, CEO Life Healthcare SA;
  • Stavros Nicolaou, senior executive - Strategic Trade Development at Aspen Pharmacare;
  • Dr Ryan Noach, deputy CEO of Discovery Health;
  • Dr Michael Mol, founding director, Hello Dr;
  • Dr Mandisa Maholwana, CEO Nelson Mandela Children's Hospital;

  • Gavin Bauer, head: Market Access, Sanofi-South Africa;

  • Dr Ronald Whelan, executive director, Healthforce and Medicare Health;

  • Gustav Praekelt, founder, Praekelt.com & Praekelt.org;
  • Dr Eugen Watson, founder, Invenico;

  • Dr Lynda Toussaint, CEO, Unjani Clinic;

  • Luke Shankland, COO Aviro Health;

  • Tanya Vogt, CEO, SAMED (South African medical technology industry association);

  • Dr Peter Cole, CEO, Lancet;

  • Dilip Naran, head of solutions at MedeMass & Mediswitch, divisions of Altron; and

  • Judy Varndell, consulting, public health sector, Deloitte.

Click here for programme agenda.

Discounts of 20% for bookings of five and more.

 

Please engage with us on Twitter: @GIBS_SA | #gibsforum, #gibsconference, #gibsevent, #gibsmba
You may also be interested in:
Sign In

We are processing your request, please be patient.